5AM Ventures V, L.P. 4
4 · Cabaletta Bio, Inc. · Filed Jan 12, 2021
Insider Transaction Report
Form 4
5AM Ventures V, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-01-08$13.00/sh−37,411$486,343→ 380,218 total(indirect: See footnotes) - Sale
Common Stock
2021-01-08$13.00/sh−264,589$3,439,657→ 2,689,045 total(indirect: See footnotes) - Sale
Common Stock
2021-01-12$13.00/sh−74,470$968,110→ 2,614,575 total(indirect: See footnotes) - Sale
Common Stock
2021-01-12$13.00/sh−10,530$136,890→ 369,688 total(indirect: See footnotes)
Footnotes (4)
- [F1]Shares are held directly by 5AM Ventures V, L.P. ("5AM V").
- [F2]5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Preferred Stock held directly by 5AM V, except to the extent of its or his pecuniary interest therein.
- [F3]Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities").
- [F4]5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.